Pharsight

Drugs that contain Ibuprofen Lysine

1. Neoprofen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8415337 RECORDATI RARE Ibuprofen compositions and methods of making same
Mar, 2032

(7 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6342530 RECORDATI RARE Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
Nov, 2020

(3 years ago)

US6344479 RECORDATI RARE Method of preventing retinopathy of prematurity in a neonate
Mar, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Apr 13, 2013

Market Authorisation Date: 13 April, 2006

Treatment: Treatment of patent ductus arteriosus; Closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500g, who are no more than 32 weeks gestational age w...

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of NEOPROFEN before it's drug patent expiration?
More Information on Dosage

NEOPROFEN family patents

Family Patents